Literature DB >> 8390317

Hepatic arterial chemoembolization for metastatic endocrine tumors.

K R Stokes1, K Stuart, M E Clouse.   

Abstract

PURPOSE: In patients with hepatic metastases from endocrine tumors, the safety and effectiveness of chemoembolization with ethiodized oil was determined and compared with those of embolization with particulate matter alone. PATIENTS AND METHODS: Twenty patients with hepatic islet cell or carcinoid tumor metastases were treated with selective hepatic artery injection of doxorubicin and iopamidol emulsified in ethiodized oil, followed by gelatin foam powder embolization.
RESULTS: In 16 patients with hormonally active tumors, hormone secretion decreased 90% (range, 69%-98%) in 10 days, with relief of symptoms in all patients. Average tumor size decrease was 84%; average hospitalization was 8 days. Seventeen patients are alive 6-27 months after embolization, and all are asymptomatic. Three patients died within 1 year after embolization of progressive disease outside the liver.
CONCLUSION: Chemoembolization with doxorubicin emulsified in ethiodized oil and iopamidol is effective in the treatment of hepatic metastases from endocrine tumors. This technique appears to result in less morbidity than particulate embolization alone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390317     DOI: 10.1016/s1051-0443(93)71871-0

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  4 in total

1.  Hepatic neuroendocrine metastases: chemo- or bland embolization?

Authors:  Susan C Pitt; Jaime Knuth; James M Keily; John C McDermott; Sharon M Weber; Hebert Chen; William S Rilling; Edward J Quebbeman; David M Agarwal; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2008-08-16       Impact factor: 3.452

2.  Palliative embolization of fibrosarcoma for control of tumor-induced hypoglycemia.

Authors:  S J Lengle; S T Hecht; D P Link; R O'Donnell
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Jul-Aug       Impact factor: 2.740

3.  Malignant insulinoma: permanent hepatic artery embolization of liver metastases--preliminary results.

Authors:  F W Winkelbauer; B Nierderle; O Graf; R Prokesch; S Thurnher; R Wildling; J Lammer
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Nov-Dec       Impact factor: 2.740

4.  Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors.

Authors:  Scott R Schell; E Ramsay Camp; James G Caridi; Irvin F Hawkins
Journal:  J Gastrointest Surg       Date:  2002 Sep-Oct       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.